These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7947871)

  • 1. Asymptomatic left ventricular dysfunction: to treat or not to treat?
    Young JB
    J Heart Lung Transplant; 1994; 13(4):S135-40. PubMed ID: 7947871
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Epstein EF
    Age Ageing; 2005 Mar; 34(2):196; author reply 196-7. PubMed ID: 15713873
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved outcome in heart failure.
    Armstrong PW
    Int J Clin Pract Suppl; 1999 Apr; 100():10-1. PubMed ID: 10658291
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in left ventricular dysfunction.
    Linn WD
    Pharmacotherapy; 1996; 16(2 Pt 2):50S-58S. PubMed ID: 8668606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure management in primary care: implications of the ATLAS study.
    Int J Clin Pract Suppl; 1999 Apr; 100():25-30. PubMed ID: 10658298
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
    Sabatini T; Rozzini R; Trabucchi M
    Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
    Pitt B
    Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 14. A hard look at angiotensin receptor blockers in heart failure.
    Gring CN; Francis GS
    J Am Coll Cardiol; 2004 Nov; 44(9):1841-6. PubMed ID: 15519017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasodilator therapy in heart failure.
    Kubo SH
    J Heart Lung Transplant; 1994; 13(4):S122-5. PubMed ID: 7947868
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of chronic heart failure.
    Cohn JN
    N Engl J Med; 1996 Aug; 335(7):490-8. PubMed ID: 8672155
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacological management of heart failure: too many treatments?
    van Veldhuisen DJ; van Gilst WH
    Eur J Heart Fail; 2003 Jan; 5(1):5-8. PubMed ID: 12559208
    [No Abstract]   [Full Text] [Related]  

  • 19. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.